4//SEC Filing
Kadlec Robert Peter 4
Accession 0000950170-24-134524
CIK 0001840229other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:10 PM ET
Size
7.3 KB
Accession
0000950170-24-134524
Insider Transaction Report
Form 4
Kadlec Robert Peter
Director
Transactions
- Award
Common Stock
2024-12-01$0.73/sh+12,286$8,969→ 12,286 total - Award
Stock Option
2024-10-30+41,745→ 41,745 totalExercise: $0.72Exp: 2034-10-30→ Common Stock (41,745 underlying)
Footnotes (2)
- [F1]The Stock Options were awarded in accordance with the MiNK Therapeutics Inc. 2021 Amended and Restated Equity Incentive Plan on October 30, 2024 and will vest in three equal annual installments on each of October 30, 2025, 2026 and 2027 (provided Dr. Kadlec maintains a service relationship with the company through each such vesting date).
- [F2]Dr. Kadlec was granted restricted stock unites ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0002047073
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:10 PM ET
- Size
- 7.3 KB